Trial Profile
Evaluation of safety and efficacy of T1h (anti-CD6) as monotherapy and in combination with methotrexate in patients with rheumatoid arthritis
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Itolizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Center of Molecular Immunology
- 12 Dec 2013 Status changed from recruiting to suspended, as per Cuban Clinical Trial Registry record
- 13 Sep 2011 New trial record